PLMR:NASDAQPalomar Holdings, Inc. Analysis
Data as of 2026-09-04 - not real-time
$136.58
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $136.58, Palomar Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. With RSI at 58.5 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $123.60 and resistance at $137.40.
On valuation the read is fair — earnings multiple of 18.4 versus a 16.5 sector average, above the peer group. Analyst price targets sit 19.5% above the current price. Revenue is growing at 54.7% on a 18.6% profit margin. The 1.32% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 34.4%, a beta of -0.25 and a maximum drawdown of 26.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
On valuation the read is fair — earnings multiple of 18.4 versus a 16.5 sector average, above the peer group. Analyst price targets sit 19.5% above the current price. Revenue is growing at 54.7% on a 18.6% profit margin. The 1.32% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 34.4%, a beta of -0.25 and a maximum drawdown of 26.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Top Market Events
Palomar Holdings Inc PLMR delivers 15th consecutive earnings beat with 27% premium growth, while navigating intense...Specialty insurance provider Palomar Holdings NASDAQ:PLMR reported Q2 CY2026 results , with sales up 54.Palomar Holdings, Inc. Reports Second Quarter 2026 Results. LA JOLLA, Calif., Aug. 04, 2026 GLOBE NEWSWIRE -- Palomar...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 125.12
- MACD momentum is positive
- Maximum drawdown of 26.1%
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 18.4 versus sector average of 16.5
- Trading above the 200-day average of 125.12
- Analyst targets imply +19.5% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 18.4 versus sector average of 16.5
- Analyst targets imply +19.5% versus the current price
- Profit margin of 18.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth54.70%
Profit Margin18.62%
P/E Ratio18.4
ROE22.23%
ROA4.99%
Debt/Equity30.15
P/B Ratio3.6
Op. Cash Flow$415.3M
Free Cash Flow$569.9M
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI58.5
Support$123.60
Resistance$137.40
MA 20$130.68
MA 50$133.91
MA 200$125.12
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Fair Value$733.21
Target Price$163.17
Upside/Downside19.47%
GradeFair
TypeBlend
Dividend Yield1.32%
Risk Assessment
Beta-0.25
Volatility34.41%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.